| Globe International Limited (GLB) ORDINARY FULLY PAID |
Consumer Discretionary |
$120 |
Appendix 4D - Half Year Accounts 27 February 2025
|
27 Feb 2025 11:09AM |
$3.440 |
$2.900 |
fallen by
15.70%
|
|
GLB - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax attributable to members is $4.76 million.
- Revenue from contracts with customers decreased by 11.7% to $95.29 million.
- EBIT margin improved to 7.5% from 6.8%.
- Interim dividend of 10 cents per share declared.
- Cash position increased to $24.6 million.
- Focus on strategic adjustments to brand mix for profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$2,504 |
Notification of cessation of securities - PDI
|
27 Feb 2025 11:06AM |
$0.343 |
$0.950 |
risen by
177.37%
|
|
| Claremont Global Fund (Hedged) (Managed Fund) (CGHE) CLAREMONT GLOBAL FUND (HEDGED) ACTIVE ETF |
Financials |
$66 |
Quarterly Portfolio Disclosure - December 2024
|
27 Feb 2025 11:01AM |
$1.785 |
$1.610 |
fallen by
9.80%
|
|
| Claremont Global Fund (Managed Fund) (CGUN) CLAREMONT GLOBAL FUND ACTIVE ETF |
Financials |
$59 |
Quarterly Portfolio Disclosure - December 2024
|
27 Feb 2025 10:56AM |
$1.850 |
$1.400 |
fallen by
24.32%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$124 |
HY25 Results Market Release
|
27 Feb 2025 10:53AM |
$0.365 |
$0.255 |
fallen by
30.14%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive free cash flow of $0.6m, an improvement of 105.3% on pcp
- Airtasker marketplaces revenue growth of 14.8% on pcp
- UK revenue growth of 99.8% on pcp
- US revenue growth of 193.3% on pcp
- $18.3m in cash and term deposits on balance sheet
- Global partnership with VCARB Formula Oneâ„¢ Team launched
- AI collaboration with OpenAI Operator launched
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$150 |
Half Year Results Webcast Presentation
|
27 Feb 2025 10:52AM |
$0.740 |
$0.625 |
fallen by
15.54%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$124 |
Half Yearly Report and Accounts
|
27 Feb 2025 10:48AM |
$0.365 |
$0.255 |
fallen by
30.14%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Airtasker reported a significant loss of $15.96 million for the half-year ended 31 December 2024.
- Statutory revenue increased by 10% to $25.66 million compared to the previous half-year.
- Marketplace revenue grew by 14.8% to $21.7 million, with a notable increase in booked tasks.
- Airtasker remains focused on expanding its marketing efforts and optimizing marketplace operations.
- The company aims to achieve positive free cash flow for the full financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$573 |
Half Year Results Presentation
|
27 Feb 2025 10:48AM |
$11.670 |
$11.410 |
fallen by
2.23%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 10.5% to $35.6 million.
- Profit before tax rose by 48.1% to $21.9 million.
- Profit after tax increased by 28.7% to $14.1 million.
- Established 93 North American Specialty Centers for SCENESSE®.
- Positive outcomes in clinical studies for vitiligo and variegate porphyria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$573 |
Half Year Results Announcement
|
27 Feb 2025 10:47AM |
$11.670 |
$11.410 |
fallen by
2.23%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 10.5% to $43.3 million.
- Profit after tax rose to $14.1 million, up 28.7%.
- Underlying earnings before tax grew by 48.1% to $21.9 million.
- Net assets increased by 7% to $217.3 million.
- Clinuvel reported consecutive half-year profits since starting commercial operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$80 |
TNC Webinar Presentation
|
27 Feb 2025 10:46AM |
$0.385 |
$0.525 |
risen by
36.36%
|
|
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$4,379 |
Final Director's Interest Notice
|
27 Feb 2025 10:45AM |
$14.460 |
$22.660 |
risen by
56.71%
|
|
| Qualitas Real Estate Income Fund (QRI) ORDINARY UNITS FULLY PAID |
Financials |
$994 |
Appendix 4D and HY24 Financial Statements
|
27 Feb 2025 10:45AM |
$1.620 |
$1.575 |
fallen by
2.78%
|
|
| Asian Investment Corporation Limited (ANV) ORDINARY FULLY PAID |
- |
- |
Next Interest Payment Date
|
27 Feb 2025 10:44AM |
n/a |
n/a |
n/a
|
|
| Renu Energy Limited (RNE) ORDINARY FULLY PAID |
Utilities |
$0 |
Consolidation/Split - RNE
|
27 Feb 2025 10:43AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$573 |
Appendix 4D and Half Year Report
|
27 Feb 2025 10:42AM |
$11.670 |
$11.410 |
fallen by
2.23%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 21.1% to $43.29 million.
- Commercial sales and reimbursements rose by 10.5%.
- Interest income up 26.1% due to favorable cash reserve management.
- Net profit before tax rose by 48.1% to $21.93 million.
- Net profit after tax increased by 28.7% to $14.08 million.
- Cash reserves reached $198.2 million.
- Three strategic programs prioritized for development: vitiligo, ACTH, and porphyrias.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Site Group International Limited (SIT) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Reinstatement to Quotation
|
27 Feb 2025 10:42AM |
$0.002 |
$0.001 |
fallen by
33.33%
|
|
| Site Group International Limited (SIT) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Market Update
|
27 Feb 2025 10:41AM |
$0.002 |
$0.001 |
fallen by
33.33%
|
|
| Havilah Resources Limited (HAV) ORDINARY FULLY PAID |
Materials |
$232 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
27 Feb 2025 10:37AM |
$0.200 |
$0.655 |
risen by
227.50%
|
|
HAV - Price-sensitive ASX Announcement
Full Release
Key Points
- Havilah reported positive drilling results from the Mutooroo project.
- Significant copper, cobalt, and gold intercepts were observed.
- High levels of beryllium and tungsten were found at the Croziers prospect.
- The company is aiming to monetize the Kalkaroo copper-gold-cobalt project.
- Engagement with interested parties for project equity interest is ongoing.
- Planning for active exploration activities across its tenements in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$190,449 |
Form 4 as filed - Francois Hardy
|
27 Feb 2025 10:32AM |
$68.840 |
$174.960 |
risen by
154.15%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$190,449 |
Form 4 as filed - Jennifer Cmil
|
27 Feb 2025 10:32AM |
$68.840 |
$174.960 |
risen by
154.15%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$190,449 |
Form 4 as filed - Karyn Ovelmen
|
27 Feb 2025 10:31AM |
$68.840 |
$174.960 |
risen by
154.15%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$190,449 |
Form 4 as filed - Natascha Viljoen
|
27 Feb 2025 10:31AM |
$68.840 |
$174.960 |
risen by
154.15%
|
|
| The Star Entertainment Group Limited (SGR) ORDINARY FULLY PAID |
Consumer Discretionary |
$830 |
Notification of change in substantial holding - State Street
|
27 Feb 2025 10:30AM |
$0.133 |
$0.125 |
fallen by
5.66%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,610 |
Neuren 2024 results investor webinar on 28 February 2025
|
27 Feb 2025 10:24AM |
$13.750 |
$12.710 |
fallen by
7.56%
|
|
| St George Mining Limited (SGQ) ORDINARY FULLY PAID |
Materials |
$610 |
Presentation - Acquisition of the Araxa Project, Brazil
|
27 Feb 2025 10:23AM |
$0.032 |
$0.160 |
risen by
400%
|
|
SGQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition completed on 26 February 2025.
- Araxá Project located in Brazil's top niobium-producing district.
- Project has more than 500 significant historical drill intercepts.
- Only 10% of the project area has been closely drilled.
- St George has established in-country management with extensive experience.
- Cooperation agreement with the State of Minas Gerais to expedite approvals.
- Niobium and REEs are critical for modern technologies and clean energy.
- Investment agreements and partnerships are in place to support project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.